Every listing scored on 371 acquisition signals.
Each business is scored across financial attractiveness, AI augmentability, scalability, strategic fit, and a fail-closed regulatory gate. Teasers are anonymized; diligence unlocks behind NDA. Bank financing is pre-positioned on every eligible deal.
$5–20M revenue imaging center — 2-state
diagnostics · CA, NV
$5–20M revenue DSO — 2-state
dental · TX, OK
$5–20M revenue ASC — CO
ASC · CO
$1–5M revenue med spa — CA
wellness-cashpay · CA
$1–5M revenue specialty practice — AZ
outpatient · AZ
$5–20M revenue DME supplier — FL
DME · FL
$5–20M revenue home health medicare — FL
home-based · FL
$5–20M revenue oxygen respiratory — TX
DME · TX
$20–50M revenue specialty pharmacy — NY
pharmacy · NY
$1–5M revenue DME supplier — TX
DME · TX
<$1M revenue compounding pharmacy — CA
pharmacy · CA
<$1M revenue specialty pharmacy — MA
pharmacy · MA
$1–5M revenue pain mgmt — FL
outpatient · FL